Amicus Therapeutics Inc (FOLD) — Tangible Net Worth Ratio
Amicus Therapeutics Inc (FOLD) has a Tangible Net Worth Ratio of 94.9% as of December 2025. This metric is calculated by deducting intangible assets ($13.91 Million) from net assets ($274.24 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Amicus Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Amicus Therapeutics Inc Tangible Net Worth Ratio (2004–2025)
This chart shows how Amicus Therapeutics Inc's Tangible Net Worth Ratio has changed across 20 annual periods from 2004 to 2025. As of December 2025, the ratio stands at 94.9%, reflecting net assets of $274.24 Million with intangible assets of $13.91 Million USD. See FOLD days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Amicus Therapeutics Inc (2004–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Amicus Therapeutics Inc from 2004 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Amicus Therapeutics Inc market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | $274.24 Million | $13.91 Million | $949.87 Million | ▲ +3.8 pp |
| 2024 | 91.1% | $194.04 Million | $17.20 Million | $785.03 Million | ▲ +3.9 pp |
| 2023 | 87.2% | $160.17 Million | $20.49 Million | $777.88 Million | ▲ +5.9 pp |
| 2022 | 81.3% | $123.05 Million | $23.00 Million | $724.17 Million | ▼ -11.2 pp |
| 2021 | 92.5% | $307.37 Million | $23.00 Million | $905.14 Million | ▲ +0.5 pp |
| 2020 | 92.0% | $286.38 Million | $23.00 Million | $886.52 Million | ▼ -3.2 pp |
| 2019 | 95.2% | $476.43 Million | $23.00 Million | $850.21 Million | ▲ +1.9 pp |
| 2018 | 93.3% | $342.91 Million | $23.00 Million | $789.95 Million | ▼ -0.2 pp |
| 2017 | 93.5% | $352.85 Million | $23.00 Million | $627.02 Million | ▲ +128.6 pp |
| 2016 | -35.1% | $360.15 Million | $486.70 Million | $1.04 Billion | ▲ +4.8 pp |
| 2015 | -39.9% | $347.83 Million | $486.70 Million | $908.38 Million | ▼ -121.1 pp |
| 2014 | 81.2% | $122.18 Million | $23.00 Million | $209.97 Million | ▲ +31.4 pp |
| 2013 | 49.7% | $45.75 Million | $23.00 Million | $127.56 Million | ▼ -50.3 pp |
| 2012 | 100.0% | $69.22 Million | $0.00 | $110.09 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $29.59 Million | $0.00 | $69.80 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $64.93 Million | $0.00 | $112.55 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $71.83 Million | $0.00 | $85.37 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $71.04 Million | $0.00 | $128.77 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $103.30 Million | $0.00 | $167.10 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $4.15 Million | $0.00 | $5.07 Million | — |